Fludrocortisone: Clinical Indications
Fludrocortisone is used as mineralocorticoid replacement therapy in patients with primary adrenal insufficiency (Addison's disease) who have confirmed aldosterone deficiency, and for salt-losing forms of congenital adrenal hyperplasia. 1, 2
Primary Indication: Primary Adrenal Insufficiency
The Endocrine Society Clinical Practice Guideline strongly recommends that all patients with confirmed aldosterone deficiency receive mineralocorticoid replacement 1. Fludrocortisone is the synthetic mineralocorticoid used for this purpose, as it maintains water and electrolyte homeostasis and thereby blood pressure 1.
Dosing Parameters
- Adults and adolescents: 0.05-0.2 mg daily, typically taken once in the morning 1, 3
- Newborns and children: Higher doses required due to lower mineralocorticoid sensitivity 1
- Dose adjustments: May need 50-100% increases in hot climates or conditions causing excessive sweating 1
Important Glucocorticoid Interactions
The fludrocortisone dose must be considered in context of concurrent glucocorticoid therapy 3:
- Hydrocortisone: Has inherent mineralocorticoid activity, so patients may require less fludrocortisone
- Prednisolone: Has reduced mineralocorticoid activity, requiring more fludrocortisone 1
- Dexamethasone: Has no mineralocorticoid activity, requiring full fludrocortisone replacement 1
Secondary Indication: Salt-Losing Congenital Adrenal Hyperplasia
Fludrocortisone is FDA-approved for salt-losing adrenogenital syndrome 2. In CAH, it prevents sodium loss and helps suppress excessive adrenal androgen production when combined with glucocorticoids 4.
Monitoring Requirements
Clinical assessment takes priority over laboratory values 1. Monitor for:
Signs of Under-Replacement
- Salt craving
- Postural hypotension or light-headedness
- Hyponatremia
- Hyperkalemia
Signs of Over-Replacement
- Peripheral edema
- Hypertension
- Hypokalemia
Laboratory Monitoring
- Electrolytes: Sodium and potassium should remain within normal range 1
- Plasma renin activity: Target the upper reference range as a useful marker for correct dosing 1, 5
- Blood pressure in sitting and standing positions 1
Critical Management Considerations
Hypertension Management
If hypertension develops on fludrocortisone 1:
- First: Reduce fludrocortisone dose
- Second: Evaluate glucocorticoid dose (over-replacement of either can cause hypertension)
- Third: If hypertension persists after adjustment, use ACE inhibitors or angiotensin II receptor blockers
- Avoid: Diuretics and aldosterone receptor blockers (spironolactone, eplerenone are contraindicated) 1
Drug Interactions to Avoid
- Licorice and grapefruit juice: Potentiate mineralocorticoid effects of hydrocortisone; should be avoided 1
- Phenytoin: Increases fludrocortisone metabolism, requiring higher replacement doses 1
Special Situations
Patients should be advised not to restrict salt intake 1. Temporary dose increases or increased salt intake may be needed during heat exposure or excessive sweating 1.
Evidence Quality Note
While fludrocortisone is the standard of care for mineralocorticoid replacement, the Endocrine Society guideline acknowledges that its use in primary adrenal insufficiency has not been studied systematically 1. The recommendations are based on physiologic principles and clinical experience rather than high-quality randomized trials. Recent research confirms that fludrocortisone demonstrates dose-dependent mineralocorticoid activity with measurable effects on sodium, potassium, and renin levels 6.